- List
- By Topic
- On Map
- Search Details

blepharospasm (52 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03641950 | Completed | The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm. |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
249 | All | 18 Years and older (Adult, Older Adult) | NCT03641950 | HG-BOT-IV3 | April 30, 2015 | May 2015 | January 7, 2016 | August 22, 2018 | August 22, 2018 |
|
|||
2 | NCT02765113 | Unknown † | Two Different Surgical Methods of Blepharospasm |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
40 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02765113 | XH-16-008 | May 2016 | December 2017 | December 2017 | May 6, 2016 | May 6, 2016 | ||||
3 | NCT03269123 | Completed | A Mechanical Device for Blepharospasm |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
58 | All | 18 Years and older (Adult, Older Adult) | NCT03269123 | 5663 | March 2, 2010 | August 8, 2011 | August 8, 2011 | August 31, 2017 | August 31, 2017 | ||||
4 | NCT02780336 | Recruiting | Blepharospasm Tools |
|
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT02780336 | IRB00087047 U54TR001456 |
August 2016 | February 2019 | February 2019 | May 23, 2016 | August 8, 2018 |
|
||||
5 | NCT01686061 | Completed | Blepharospasm Patient Survey for Patients With Blepharospasm |
|
|
Observational |
|
Industry |
|
124 | All | 18 Years to 81 Years (Adult, Older Adult) | NCT01686061 | MUS6020100920 | September 2012 | April 2013 | April 2013 | September 17, 2012 | April 8, 2014 |
|
|||||
6 | NCT03263000 | Recruiting | Photic Blink Reflex in People With Blepharospasm and Increased Blinking |
|
Observational |
|
NIH |
|
|
72 | All | 18 Years and older (Adult, Older Adult) | NCT03263000 | 170159 17-N-0159 |
October 30, 2017 | December 31, 2019 | December 31, 2019 | August 28, 2017 | June 27, 2018 |
|
|||||
7 | NCT02327728 | Unknown † | Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT02327728 | ZOC00173 | February 2013 | December 2015 | December 2015 | December 30, 2014 | December 30, 2014 |
|
|||
8 | NCT01287247 | Completed | Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States |
|
|
Observational |
|
Industry / Other |
|
|
688 | All | 18 Years and older (Adult, Older Adult) | NCT01287247 | MRZ 60201-4066-5 | XCiDaBLE | February 2011 | April 2013 | April 2013 | February 1, 2011 | April 10, 2015 |
|
|||
9 | NCT01750346 | Terminated Has Results |
Acetyl Hexapeptide-8 for Blepharospasm |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
8 | All | 18 Years and older (Adult, Older Adult) | NCT01750346 | 130022 13-N-0022 |
November 2012 | May 2015 | May 2015 | December 17, 2012 | November 10, 2016 | November 10, 2016 |
|
||
10 | NCT00942851 | Completed Has Results |
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm |
|
|
Interventional |
Phase 1 Phase 2 |
|
NIH / Industry |
|
|
24 | All | 18 Years and older (Adult, Older Adult) | NCT00942851 | 090193 09-N-0193 |
July 2009 | October 2010 | October 2010 | July 21, 2009 | September 6, 2012 | September 6, 2012 |
|
||
11 | NCT02947815 | Unknown † | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm |
|
|
Interventional |
Phase 2 Phase 3 |
|
Industry |
|
|
234 | All | 18 Years and older (Adult, Older Adult) | NCT02947815 | DW_DWP450007 | October 2016 | October 2017 | December 2017 | October 28, 2016 | October 28, 2016 |
|
|||
12 | NCT00682760 | Completed | Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
60 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00682760 | Meditoxin_Botox Meditoxin-05-01 |
October 2005 | February 2006 | August 2006 | May 22, 2008 | May 22, 2008 |
|
|||
13 | NCT00761592 | Completed Has Results |
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
65 | All | 18 Years and older (Adult, Older Adult) | NCT00761592 | ALLBL001 | July 2006 | January 2008 | January 2008 | September 29, 2008 | November 19, 2013 | July 9, 2009 |
|
||
14 | NCT03216473 | Completed | Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
140 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03216473 | TG1221MED | May 25, 2016 | March 17, 2017 | July 4, 2017 | July 13, 2017 | July 13, 2017 | ||||
15 | NCT02370875 | Completed | rTMS and Botulinum Toxin in Benign Essential Blepharospasm |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
25 | All | 30 Years to 75 Years (Adult, Older Adult) | NCT02370875 | 201400993 | February 2015 | May 2017 | November 2017 | February 25, 2015 | December 13, 2017 |
|
|||
16 | NCT01259557 | Completed | Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
110 | All | 18 Years and older (Adult, Older Adult) | NCT01259557 | MT-PRT-BP02 | August 2010 | May 2011 | August 2011 | December 14, 2010 | April 25, 2012 |
|
|||
17 | NCT00234507 | Completed | Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT00234507 | Y-47-52120-706 | January 2003 | May 2004 | October 7, 2005 | December 13, 2018 |
|
||||
18 | NCT00500799 | Completed | Brain Changes in Blepharospasm |
|
Observational |
|
NIH |
|
72 | All | 18 Years and older (Adult, Older Adult) | NCT00500799 | 070191 07-N-0191 |
July 9, 2007 | April 14, 2009 | July 13, 2007 | July 2, 2017 |
|
|||||||
19 | NCT00406367 | Completed Has Results |
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
109 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00406367 | MRZ 60201-0433 | October 2006 | April 2008 | July 2009 | December 4, 2006 | March 15, 2013 | November 16, 2010 |
|
||
20 | NCT00507637 | Terminated | Blepharospasm Short Interval |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
8 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT00507637 | MRZ 60201-0703/1 2007-000697-23 |
August 2007 | February 2008 | February 2008 | July 26, 2007 | February 6, 2012 |
|
|||
21 | NCT01791881 | Completed | Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
172 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01791881 | HG-06-01 | April 2008 | May 2009 | July 2009 | February 15, 2013 | February 15, 2013 |
|
|||
22 | NCT01896895 | Completed Has Results |
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
61 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01896895 | MRZ60201_3074_1 2012-004821-26 |
November 2013 | April 2016 | November 2016 | July 11, 2013 | March 1, 2018 | March 1, 2018 |
|
||
23 | NCT01759745 | Unknown † | Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm |
|
Observational |
|
Other |
|
|
40 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01759745 | BEB_Gaze_Emotion | December 2014 | December 2015 | December 2015 | January 3, 2013 | July 1, 2014 |
|
|||||
24 | NCT00411255 | Completed | Brain Stimulation to Treat Blepharospasm or Meige Syndrome |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
22 | All | 18 Years and older (Adult, Older Adult) | NCT00411255 | 060192 06-N-0192 |
June 22, 2006 | April 7, 2009 | April 7, 2009 | December 13, 2006 | July 2, 2017 |
|
|||
25 | NCT01814774 | Completed Has Results |
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm |
|
|
Observational |
|
Industry |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT01814774 | TRU2011 | January 2013 | July 2013 | July 2013 | March 20, 2013 | July 3, 2014 | July 3, 2014 |
|
|||
26 | NCT02245958 | Completed | A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm |
|
|
Observational |
|
Industry |
|
|
44 | All | 18 Years and older (Adult, Older Adult) | NCT02245958 | GMA-US-NEU-0271 | August 2015 | December 2015 | December 2015 | September 22, 2014 | January 8, 2016 |
|
||||
27 | NCT02577224 | Unknown † | An RCT of a Patient-initiated Treatment Service for BEB and HFS |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
130 | All | 18 Years and older (Adult, Older Adult) | NCT02577224 | EZRD1024 | August 2015 | October 2017 | October 2017 | October 16, 2015 | March 22, 2017 |
|
|||
28 | NCT03508882 | Active, not recruiting | Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03508882 | HMRF Project No.: 12133171 Protocol : MMBT; v1.3;1Mar16 |
July 1, 2015 | October 31, 2017 | April 30, 2018 | April 26, 2018 | May 1, 2018 | ||||
29 | NCT00487383 | Terminated | Brain Changes in Blepharospasm |
|
Observational |
|
NIH |
|
47 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT00487383 | 070165 07-N-0165 |
June 12, 2007 | June 29, 2012 | June 18, 2007 | February 15, 2019 |
|
|||||||
30 | NCT01546805 | Unknown † | Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT01546805 | R.P. #11-3601 | April 2012 | December 2012 | March 2013 | March 7, 2012 | March 7, 2012 |
|
|||
31 | NCT01168388 | Completed | Movement Disorder Survey in East China |
|
Observational |
|
Other / Industry |
|
|
1600 | All | Child, Adult, Older Adult | NCT01168388 | SirRRSH-001 | MDS | April 2010 | August 2010 | August 2010 | July 23, 2010 | July 21, 2011 |
|
||||
32 | NCT03399292 | Recruiting | Effect of Lipid Based Eye Drops on Tear Film Lipid Layer Thickness |
|
|
Observational |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT03399292 | OPHT-031116 | April 12, 2017 | August 2019 | December 2019 | January 16, 2018 | June 8, 2018 |
|
||||
33 | NCT00535938 | Completed Has Results |
MDs on Botox Utility (MOBILITY) |
|
|
Observational |
|
Industry |
|
|
1372 | All | 14 Years and older (Child, Adult, Older Adult) | NCT00535938 | AGN/MMC B00705 | September 2007 | September 2013 | September 2013 | September 27, 2007 | September 10, 2014 | September 10, 2014 |
|
|||
34 | NCT00001784 | Completed | Mexiletine for the Treatment of Focal Dystonia |
|
|
Interventional |
Phase 2 |
|
NIH |
|
24 | All | Child, Adult, Older Adult | NCT00001784 | 980130 98-N-0130 |
July 1998 | July 2002 | November 4, 1999 | March 4, 2008 |
|
|||||
35 | NCT03184597 | Recruiting | HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
4000 | All | Child, Adult, Older Adult | NCT03184597 | 2017-hs-30 | August 1, 2017 | June 2021 | June 2021 | June 12, 2017 | September 5, 2018 |
|
|||
36 | NCT01373424 | Recruiting | The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias |
|
Observational |
|
Other / NIH / Industry |
|
|
5000 | All | 18 Years and older (Adult, Older Adult) | NCT01373424 | IRB00046266 U54TR001456 RDCRN#6301 U54NS065701 |
DCP | January 2011 | June 2020 | August 2021 | June 15, 2011 | August 8, 2018 |
|
||||
37 | NCT03373162 | Completed | Functional Effects of Botox on the Brain Using MRS and fMRI |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
10 | Female | 30 Years to 40 Years (Adult) | NCT03373162 | 2017-3377 | September 30, 2017 | November 1, 2017 | November 1, 2017 | December 14, 2017 | February 5, 2018 |
|
|||
38 | NCT02112097 | Unknown † | ASIS for Enbrel in Plaque Psoriasis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
60 | All | 21 Years to 65 Years (Adult, Older Adult) | NCT02112097 | NCTAR066986 R44AR066986 |
ASISinPP | January 2016 | June 2016 | June 2017 | April 11, 2014 | June 24, 2015 |
|
||
39 | NCT02555982 | Unknown † | Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor |
|
|
Interventional |
Phase 3 |
|
Other / Industry |
|
|
120 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02555982 | CHU-0245 2015-000162-59 |
Btx-HT | June 2016 | July 2017 | December 2017 | September 22, 2015 | July 26, 2016 |
|
||
40 | NCT02604186 | Completed | Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other / Industry |
|
|
55 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02604186 | CAAE: 48177315.9.1001.5404 | SPASTOX | March 9, 2016 | March 15, 2017 | March 15, 2017 | November 13, 2015 | November 7, 2017 |
|
||
41 | NCT03186001 | Not yet recruiting | Frontalis Botulinum Toxin |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
30 | Female | 30 Years to 60 Years (Adult) | NCT03186001 | USJ-06 | July 1, 2017 | August 1, 2017 | August 1, 2017 | June 14, 2017 | June 14, 2017 |
|
|||
42 | NCT01233999 | Completed Has Results |
Botulinum Toxin in the Treatment of Raynaud's |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
10 | All | 18 Years to 89 Years (Adult, Older Adult) | NCT01233999 | IRB00015510 | October 2010 | October 2011 | March 2012 | November 4, 2010 | April 21, 2014 | April 21, 2014 |
|
||
43 | NCT02179450 | Completed | Cognitive Function and Emotional Possessing in Bilateral Facial Palsy |
|
Observational |
|
Other |
|
|
84 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02179450 | Cognition_Facial palsy | August 2012 | May 2013 | December 2013 | July 1, 2014 | July 1, 2014 |
|
|||||
44 | NCT00753831 | Completed | Efficacy of Aurosling in Frontalis Sling Suspension Surgery |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
16 | All | Child, Adult, Older Adult | NCT00753831 | 2PR1220827 | January 2009 | July 2009 | August 2009 | September 17, 2008 | July 12, 2012 |
|
|||
45 | NCT02196155 | Recruiting | Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
54 | All | 18 Years to 60 Years (Adult) | NCT02196155 | 32003B_152671 | July 2016 | December 2020 | June 2021 | July 21, 2014 | October 3, 2018 |
|
|||
46 | NCT00210431 | Completed | Post Marketing Surveillance Study of Dysport |
|
Observational |
|
Industry |
|
|
800 | All | 2 Years and older (Child, Adult, Older Adult) | NCT00210431 | Y-47-52120-093 | October 2004 | June 2006 | September 21, 2005 | January 25, 2019 |
|
||||||
47 | NCT00773604 | Completed | Deep Brain Stimulation in Patients With Dystonia |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
22 | All | 7 Years to 80 Years (Child, Adult, Older Adult) | NCT00773604 | Private donor | STN DBS | June 2008 | February 2015 | February 2015 | October 16, 2008 | August 7, 2015 |
|
||
48 | NCT00082615 | Completed | Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives |
|
Observational |
|
NIH | 210 | All | 18 Years and older (Adult, Older Adult) | NCT00082615 | 040188 04-N-0188 |
May 11, 2004 | April 21, 2008 | May 13, 2004 | July 2, 2017 |
|
||||||||
49 | NCT02570932 | Completed | Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02570932 | CME-LEM3 2014-005613-24 |
July 2015 | December 4, 2017 | December 4, 2017 | October 7, 2015 | April 5, 2018 |
|
|||
50 | NCT02291861 | Completed Has Results |
Addressing Involuntary Movements in Tardive Dyskinesia |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
298 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02291861 | SD-809-C-23 2014-003135-19 |
AIM-TD | October 2014 | August 2016 | August 2016 | November 17, 2014 | May 14, 2018 | April 11, 2018 |
|
|
51 | NCT02195700 | Completed Has Results |
Aim to Reduce Movements in Tardive Dyskinesia |
|
|
Interventional |
Phase 2 Phase 3 |
|
Industry |
|
|
117 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02195700 | SD-809-C-18 | ARM-TD | June 2014 | May 2015 | May 2015 | July 21, 2014 | April 17, 2018 | March 20, 2018 |
|
|
52 | NCT03254186 | Recruiting | Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
15 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03254186 | IRB00096912 | September 18, 2017 | February 1, 2019 | February 1, 2019 | August 18, 2017 | September 28, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.